SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-304662
Filing Date
2017-10-05
Accepted
2017-10-05 16:30:56
Documents
3
Period of Report
2017-10-02
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d462461d8k.htm 8-K 22266
2 EX-3.1 d462461dex31.htm EX-3.1 26170
3 EX-3.2 d462461dex32.htm EX-3.2 95370
  Complete submission text file 0001193125-17-304662.txt   145168
Mailing Address 500 TOTTEN POND ROAD WALTHAM MA 02451
Business Address 500 TOTTEN POND ROAD WALTHAM MA 02451 781-209-6400
Deciphera Pharmaceuticals, Inc. (Filer) CIK: 0001654151 (see all company filings)

IRS No.: 200299725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38219 | Film No.: 171124879
SIC: 2834 Pharmaceutical Preparations